At a glance
ClinicalIndex Comparison RecordN/ACompleted· 15,965 enrolled
Drug / intervention
AI-enabled ECG-based Screening Toolother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Applying an Artificial Intelligence-Enabled Electrocardiographic System for Reducing Mortality: a Pragmatic Randomized Clinical Trial
In Brief
A clinical study evaluating AI-enabled ECG-based Screening Tool for Cardiovascular Diseases and 2 related conditions. Completed, enrolled 15,965 participants across 1 site.
Detailed Summary
This is a randomized controlled trial (RCT) to test a novel artificial intelligence (AI)-enabled electrocardiogram (ECG)-based screening tool for early detection of clinical deterioration for reducing mortality.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsCardiovascular Diseases, Intensity Care, Morality
CountriesTaiwan
Collaborators--
Timeline
N/ACompletedFinished
20222023202420252026
First PostedNov 2021
Enrollment StartDec 2021
Primary CompletionApr 2022
Study CompletionDec 2022
TodayJul 2026
First PostedNov 11, 2021
Enrollment StartDec 15, 2021
Primary CompletionApr 30, 2022
Study CompletionDec 31, 2022
TodayJul 2, 2026
Enrollment to primary: 5 monthsPosted 4.6 years ago
Interventions
AI-enabled ECG-based Screening Toolother
Primary care clinicians in the intervention group had access to the report, which shows the risk prediction results for each patients. Moreover, the clinicians will recieve a short message when patients with a high risk ECG identified by AI.